<DOC>
	<DOCNO>NCT02786992</DOCNO>
	<brief_summary>This prospective randomize double-blind clinical trial conduct Ain-Shams University Maternity Hospital , Cairo , Egypt . Patients eligible elective low segment cesarean section randomize 2 group . Group 1 : receive 400 ug misoprostol follow + 10 IU oxytocin intravenous slowly cord clamping . Group 2 : receive 100 ug carbetocin intravenous cord clamping .</brief_summary>
	<brief_title>Misoprostol+Oxytocin vs. Carbetocin CS</brief_title>
	<detailed_description />
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Women singleton pregnancy Women schedule elective CS full term ( gestational age â‰¥37 week ) . hypersensitivity oxytocin , carbetocin prostaglandin contraindication prostaglandin ( e.g . glaucoma ) history significant heart disease severe asthma epilepsy history evidence liver renal vascular disease history coagulopathy thrombocytopenia anticoagulant therapy woman HELLP syndrome eclampsia woman present placental abruption contraindication spinal anesthesia carbetocin license use regional anesthesia .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Misoprostol</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Carbetocin</keyword>
	<keyword>Prevention</keyword>
	<keyword>Post-partum hemorrhage</keyword>
</DOC>